• Express Pharma Online
  • Express Healthcare
  • Express Computer Online
  • Express Hospitality
  • Express Travel World

Lupin to launch Bayer generic tabs Yasmin

Lupin’s Drospirenone and Ethinyl Estradiol tablets are a combined oral contraceptive for women

Lupin Pharmaceuticals has received final approval for its Drospirenone and Ethinyl Estradiol Tablets, 3 mg / 0.03 mg from the United States Food and Drugs Administration (US FDA) to market a generic version of Bayer Healthcare’s (Bayer) Yasmin tablets 3 mg / 0.03 mg.

Lupin’s Drospirenone and Ethinyl Estradiol tablets are the AB rated generic equivalent of Bayer’s Yasmin tablets 3 mg / 0.03 mg. Lupin’s Drospirenone and Ethinyl Estradiol tablets are a combined oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Lupin will be marketing its Drospirenone and Ethinyl Estradiol tablets USP in a wallet pack of 28 tablets consisting of 21 yellow active tablets, each containing 3 mg Drospirenone and 0.03 mg Ethinyl Estradiol, and seven white inert tablets.

Yasmin tablets had annual US sales of approximately $275.1 million.

EP News Bureau - Mumbai

Add comment

Name

Email

Security code
Refresh








  • Magnitude of the problem of chronic disease, NCDs in India are substantial is growing
  • Becoming sedentary is giving birth to NCDs
  • India is the largest exporter of doctors and healthcare workers
  • We want to be diabetes care capital of the world
  • We can not expect govt to do any change
  • Indian do not consider healthcare as a priority
Previous Next